BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 38634597)

  • 21. Redox Imbalance and Mitochondrial Release of Apoptogenic Factors at the Forefront of the Antitumor Action of Mango Peel Extract.
    Lo Galbo V; Lauricella M; Giuliano M; Emanuele S; Carlisi D; Calvaruso G; De Blasio A; Di Liberto D; D'Anneo A
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity.
    Romeo G; Ciaffaglione V; Amata E; Dichiara M; Calabrese L; Vanella L; Sorrenti V; Grosso S; D'Amico AG; D'Agata V; Intagliata S; Salerno L
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34202711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary
    Salerno L; Vanella L; Sorrenti V; Consoli V; Ciaffaglione V; Fallica AN; Canale V; Zajdel P; Pignatello R; Intagliata S
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1378-1386. PubMed ID: 34167427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Diverse Roles of Heme Oxygenase-1 in Tumor Progression.
    Luu Hoang KN; Anstee JE; Arnold JN
    Front Immunol; 2021; 12():658315. PubMed ID: 33868304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ROS-Dependent ER Stress and Autophagy Mediate the Anti-Tumor Effects of Tributyltin (IV) Ferulate in Colon Cancer Cells.
    Celesia A; Morana O; Fiore T; Pellerito C; D'Anneo A; Lauricella M; Carlisi D; De Blasio A; Calvaruso G; Giuliano M; Emanuele S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines.
    Shiga T; Hiraide M
    Curr Treat Options Oncol; 2020 Mar; 21(4):27. PubMed ID: 32266582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells.
    Ciaffaglione V; Intagliata S; Pittalà V; Marrazzo A; Sorrenti V; Vanella L; Rescifina A; Floresta G; Sultan A; Greish K; Salerno L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in heme oxygenase research.
    Surh YJ; Chung HT; Na HK; Dulak J; Stec DE
    Arch Biochem Biophys; 2020 May; 685():108321. PubMed ID: 32105660
    [No Abstract]   [Full Text] [Related]  

  • 29. Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors.
    Intagliata S; Salerno L; Ciaffaglione V; Leonardi C; Fallica AN; Carota G; Amata E; Marrazzo A; Pittalà V; Romeo G
    Eur J Med Chem; 2019 Dec; 183():111703. PubMed ID: 31550661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.
    Mucha O; Podkalicka P; Mikulski M; Barwacz S; Andrysiak K; Biela A; Mieczkowski M; Kachamakova-Trojanowska N; Ryszawy D; Białas A; Szelążek B; Grudnik P; Majewska E; Michalik K; Jakubiec K; Bień M; Witkowska N; Gluza K; Ekonomiuk D; Sitarz K; Gałęzowski M; Brzózka K; Dubin G; Józkowicz A; Dulak J; Łoboda A
    Arch Biochem Biophys; 2019 Aug; 671():130-142. PubMed ID: 31276659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy as a molecular target for cancer treatment.
    Kocaturk NM; Akkoc Y; Kig C; Bayraktar O; Gozuacik D; Kutlu O
    Eur J Pharm Sci; 2019 Jun; 134():116-137. PubMed ID: 30981885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethanol-Mediated Stress Promotes Autophagic Survival and Aggressiveness of Colon Cancer Cells via Activation of Nrf2/HO-1 Pathway.
    Cernigliaro C; D'Anneo A; Carlisi D; Giuliano M; Marino Gammazza A; Barone R; Longhitano L; Cappello F; Emanuele S; Distefano A; Campanella C; Calvaruso G; Lauricella M
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30974805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
    Salerno L; Floresta G; Ciaffaglione V; Gentile D; Margani F; Turnaturi R; Rescifina A; Pittalà V
    Eur J Med Chem; 2019 Apr; 167():439-453. PubMed ID: 30784878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines.
    Sorrenti V; Pittalà V; Romeo G; Amata E; Dichiara M; Marrazzo A; Turnaturi R; Prezzavento O; Barbagallo I; Vanella L; Rescifina A; Floresta G; Tibullo D; Di Raimondo F; Intagliata S; Salerno L
    Eur J Med Chem; 2018 Oct; 158():937-950. PubMed ID: 30261468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation.
    Greish KF; Salerno L; Al Zahrani R; Amata E; Modica MN; Romeo G; Marrazzo A; Prezzavento O; Sorrenti V; Rescifina A; Floresta G; Intagliata S; Pittalà V
    Molecules; 2018 May; 23(5):. PubMed ID: 29783634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors.
    Salerno L; Amata E; Romeo G; Marrazzo A; Prezzavento O; Floresta G; Sorrenti V; Barbagallo I; Rescifina A; Pittalà V
    Eur J Med Chem; 2018 Mar; 148():54-62. PubMed ID: 29454190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid Compounds as Direct Multitarget Ligands: A Review.
    de Oliveira Pedrosa M; Duarte da Cruz RM; de Oliveira Viana J; de Moura RO; Ishiki HM; Barbosa Filho JM; Diniz MF; Scotti MT; Scotti L; Bezerra Mendonca FJ
    Curr Top Med Chem; 2017; 17(9):1044-1079. PubMed ID: 27697048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic resistance in colorectal cancer: a review.
    Hammond WA; Swaika A; Mody K
    Ther Adv Med Oncol; 2016 Jan; 8(1):57-84. PubMed ID: 26753006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heme oxygenase-1 promotes tumor progression and metastasis of colorectal carcinoma cells by inhibiting antitumor immunity.
    Seo GS; Jiang WY; Chi JH; Jin H; Park WC; Sohn DH; Park PH; Lee SH
    Oncotarget; 2015 Aug; 6(23):19792-806. PubMed ID: 26087182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy.
    Mohelnikova-Duchonova B; Melichar B; Soucek P
    World J Gastroenterol; 2014 Aug; 20(30):10316-30. PubMed ID: 25132748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.